Cost Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in Older Adults in Portugal [0.03%]
葡萄牙老年人带状疱疹佐剂重组亚单位疫苗的成本效益分析
Eleftherios Zarkadoulas,Fábio Silva,Joana Alves et al.
Eleftherios Zarkadoulas et al.
Background and objectives: Herpes zoster (HZ) and associated complications comprise a considerable public health burden in older adults. This study aimed to evaluate the cost-effectiveness of recombinant zoster vaccine (R...
Valuing Maintenance of Visual Function in Retinitis Pigmentosa: A Discrete Choice Experiment with Patients and the General Public [0.03%]
视网膜色素变性患者的视觉功能维持医疗价值定量研究：一种离散选择实验方法
Kevin Marsh,Myrto Trapali,Mike Ingham et al.
Kevin Marsh et al.
Background and objectives: Retinitis pigmentosa (RP) is a progressive and sight-threatening condition with few treatment options. Patients with RP experience variable progressive vision deterioration that can severely aff...
Understanding the Humanistic Burden of Metabolic Dysfunction-Associated Steatohepatitis Liver Disease in the US Population: Age/Sex Stratified Analysis of Morbidity and Mortality [0.03%]
美国代谢紊乱相关非酒精性脂肪肝病的人文负担——基于年龄/性别分层的疾病和死亡分析
Andrew H Briggs,Ziyi Lin,Daniel Aggio et al.
Andrew H Briggs et al.
Background and aims: Metabolic dysfunction-associated steatohepatitis (MASH) is defined by a buildup of fat in the liver and signs of inflammation and liver damage (fibrosis). Eventually, subjects with MASH may develop ci...
Comparative Cost-Effectiveness Analysis of Multiple First-Line Treatments for HER2-Negative Unresectable Advanced or Recurrent Gastric Cancer in Japan [0.03%]
日本HER2阴性不可切除晚期或复发胃癌一线治疗的多种疗法成本效益分析比较研究
Kosuke Morimoto,Kensuke Moriwaki,Yoshitaka Nishikawa et al.
Kosuke Morimoto et al.
Background/objective: HER2-negative unresectable advanced or recurrent gastric cancer (GC) has a poor prognosis. This study evaluated the comparative cost-effectiveness of multiple first-line treatment options from the Ja...
Value of Emerging and Existing Pre-prophylaxis and Therapeutic Options for COVID-19 in Transplant Recipients: A Systematic Review of Economic Evaluations [0.03%]
移植受者中新兴和现有的先兆性和治疗性COVID-19选项的价值：经济评估的系统评价
Alyssa Grant,Dima Kabbani,Andrew Vuong et al.
Alyssa Grant et al.
Background: High-risk populations, including transplant recipients, are at increased risk of severe Coronavirus disease 2019 (COVID-19) outcomes. Certain treatments and pre-exposure prophylaxis (PrEP) have been approved t...
Assessing the Expected Costs of Continuous Remote Monitoring for Post-Discharge Home Use and the Readmission Reduction Required to Achieve Cost Neutrality [0.03%]
连续远程监测的预期成本及入院率降低以实现收支平衡所需达到的程度评估
Arendse Tange Larsen,Liza Sopina,Eske Kvanner Aasvang et al.
Arendse Tange Larsen et al.
Background/objective: Hospital-level care at home is gaining traction, but evidence on health economic implications remains limited. The aim of this study was to estimate expected costs of continuous remote monitoring of ...
A Cost-Analysis and Micro-Costing Study of the Man Van Project: Comparing Prostate-Specific Antigen Testing Via a Nurse-Led Mobile Service with Primary Care [0.03%]
基于护士的流动服务和初级保健的前列腺特异性抗原检测的成本分析与微观成本研究：个案研究แมนvanished van项目成本及微量成本分析研究：将基于护工的移动服务与基础护理进行对比，以进行前列腺特异性抗原检验
Masood Moghul,Deokhee Yi,Fionnuala Croft et al.
Masood Moghul et al.
Background: The Man Van project is designed to address health inequalities and barriers to accessing healthcare related to the early diagnosis of prostate cancer with novel community-based targeting of high-risk groups us...
Content Validity of Two Generic Preference-Based Measures in Retinitis Pigmentosa, Including X-Linked Retinitis Pigmentosa [0.03%]
两种通用基于偏好的量表在视网膜色素变性（包括X连锁视网膜色素变性）中的内容有效性
Louis S Matza,Timothy A Howell,Qiaoyi Zhang et al.
Louis S Matza et al.
Introduction: Retinitis pigmentosa (RP) is a group of retinal diseases characterized by night blindness and impairment in visual field and acuity. The most severe form of RP is X-linked RP (XLRP). The relevance of common ...
Incremental Disease Burden (Healthcare Costs and Resources) of Duchenne Muscular Dystrophy in the US: A Matched Cohort Analysis [0.03%]
美国杜氏肌营养不良症疾病负担（医疗费用和资源）的增量：匹配队列分析
Mena Scavina,Nate Posner,Patricia Dorling et al.
Mena Scavina et al.
Background: Duchenne muscular dystrophy (DMD) is a rare genetic condition that causes progressive muscle weakness and reduced life expectancy. Detailed economic studies on the impact of DMD disease burden, costs, and heal...
Cost-Effectiveness of RefluxStop Versus Nissen Fundoplication and Proton Pump Inhibitors for Refractory Gastroesophageal Reflux Disease: A Spanish Healthcare Perspective [0.03%]
从西班牙医疗保健的角度看，与尼森手术和质子泵抑制剂相比，抗反流支架RefuflStop治疗难治性胃食管反流病的成本效益分析
Sam Harper,Khanh Ha Bui,Stuart Mealing et al.
Sam Harper et al.
Background: Gastroesophageal reflux disease (GERD) affects 6.8 million individuals in Spain, incurring €56 million/year in healthcare costs. Standard-of-care treatment (SOC) in Spain includes medical management with prot...